The intelligent diabetes telemonitoring using decision support to treat patients on insulin therapy (DiaTRUST) trial: study protocol for a randomized controlled trial
Abstract Background Diabetes affects 10.5% of adults globally, with type 2 diabetes accounting for 90–95% of cases. Achieving optimal glycemic control is crucial yet challenging, particularly with insulin therapy, where 30–50% of patients fail to meet treatment targets. Telemedicine can improve diab...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | Trials |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13063-024-08588-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846171704322162688 |
|---|---|
| author | Camilla H. N. Thomsen Jannie T. D. Nørlev Stine Hangaard Morten H. Jensen Ole Hejlesen Sarah R. Cohen Allan Kofoed-Enevoldsen Sika N. S. Kristensen Tinna B. Aradóttir Anne Kaas Peter Vestergaard Thomas Kronborg |
| author_facet | Camilla H. N. Thomsen Jannie T. D. Nørlev Stine Hangaard Morten H. Jensen Ole Hejlesen Sarah R. Cohen Allan Kofoed-Enevoldsen Sika N. S. Kristensen Tinna B. Aradóttir Anne Kaas Peter Vestergaard Thomas Kronborg |
| author_sort | Camilla H. N. Thomsen |
| collection | DOAJ |
| description | Abstract Background Diabetes affects 10.5% of adults globally, with type 2 diabetes accounting for 90–95% of cases. Achieving optimal glycemic control is crucial yet challenging, particularly with insulin therapy, where 30–50% of patients fail to meet treatment targets. Telemedicine can improve diabetes management but generates vast amounts of data, burdening healthcare professionals. Integrating clinical decision support tools into telemonitoring systems may enhance care efficiency and glycemic control. Methods The trial is a multicenter 3-month, three-arm, open-label, randomized controlled trial. The trial aims to enroll 51 participants with type 2 diabetes on insulin therapy. Participants will be divided with a 3:1:1 ratio into telemonitoring with decision support, telemonitoring without decision support, and usual care groups. The study employs connected insulin pens, continuous glucose monitors (CGMs), and activity trackers to enable telemonitoring. Outcomes measured include CGM time in range, HbA1c, hypo- and hyperglycemia incidents, total daily insulin dose, body weight, treatment satisfaction, and adherence. Discussion Telemonitoring with decision support has the potential to revolutionize diabetes management by offering personalized treatment suggestions, thereby reducing the burden on healthcare professionals, and improving patient outcomes. This study will provide valuable insights into the effectiveness of such an approach in achieving glycemic control in people with type 2 diabetes on insulin therapy. By evaluating both clinical outcomes and patient and healthcare professionals’ satisfaction, the study aims to contribute to the development of efficient, scalable telehealth solutions for diabetes care. Trial registration ClinicalTrials.gov NCT06185296. Registered on December 14, 2023. |
| format | Article |
| id | doaj-art-e5cbb1dfaf614af6a8564c04c28c2b5d |
| institution | Kabale University |
| issn | 1745-6215 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | BMC |
| record_format | Article |
| series | Trials |
| spelling | doaj-art-e5cbb1dfaf614af6a8564c04c28c2b5d2024-11-10T12:41:45ZengBMCTrials1745-62152024-11-0125111110.1186/s13063-024-08588-7The intelligent diabetes telemonitoring using decision support to treat patients on insulin therapy (DiaTRUST) trial: study protocol for a randomized controlled trialCamilla H. N. Thomsen0Jannie T. D. Nørlev1Stine Hangaard2Morten H. Jensen3Ole Hejlesen4Sarah R. Cohen5Allan Kofoed-Enevoldsen6Sika N. S. Kristensen7Tinna B. Aradóttir8Anne Kaas9Peter Vestergaard10Thomas Kronborg11Steno Diabetes Center North DenmarkSteno Diabetes Center North DenmarkSteno Diabetes Center North DenmarkDepartment of Health Science and Technology, Aalborg UniversityDepartment of Health Science and Technology, Aalborg UniversityDepartment of Endocrinology, Zealand University Hospital - Nykøbing FalsterDepartment of Endocrinology, Zealand University Hospital - Nykøbing FalsterCompanion SaMD Solutions, Novo Nordisk A/SCompanion SaMD Solutions, Novo Nordisk A/SMedical & Science, Devices and Digital Health, Novo Nordisk A/SSteno Diabetes Center North DenmarkSteno Diabetes Center North DenmarkAbstract Background Diabetes affects 10.5% of adults globally, with type 2 diabetes accounting for 90–95% of cases. Achieving optimal glycemic control is crucial yet challenging, particularly with insulin therapy, where 30–50% of patients fail to meet treatment targets. Telemedicine can improve diabetes management but generates vast amounts of data, burdening healthcare professionals. Integrating clinical decision support tools into telemonitoring systems may enhance care efficiency and glycemic control. Methods The trial is a multicenter 3-month, three-arm, open-label, randomized controlled trial. The trial aims to enroll 51 participants with type 2 diabetes on insulin therapy. Participants will be divided with a 3:1:1 ratio into telemonitoring with decision support, telemonitoring without decision support, and usual care groups. The study employs connected insulin pens, continuous glucose monitors (CGMs), and activity trackers to enable telemonitoring. Outcomes measured include CGM time in range, HbA1c, hypo- and hyperglycemia incidents, total daily insulin dose, body weight, treatment satisfaction, and adherence. Discussion Telemonitoring with decision support has the potential to revolutionize diabetes management by offering personalized treatment suggestions, thereby reducing the burden on healthcare professionals, and improving patient outcomes. This study will provide valuable insights into the effectiveness of such an approach in achieving glycemic control in people with type 2 diabetes on insulin therapy. By evaluating both clinical outcomes and patient and healthcare professionals’ satisfaction, the study aims to contribute to the development of efficient, scalable telehealth solutions for diabetes care. Trial registration ClinicalTrials.gov NCT06185296. Registered on December 14, 2023.https://doi.org/10.1186/s13063-024-08588-7Diabetes careType 2 diabetesTelemonitoringClinical decision supportInsulin therapy |
| spellingShingle | Camilla H. N. Thomsen Jannie T. D. Nørlev Stine Hangaard Morten H. Jensen Ole Hejlesen Sarah R. Cohen Allan Kofoed-Enevoldsen Sika N. S. Kristensen Tinna B. Aradóttir Anne Kaas Peter Vestergaard Thomas Kronborg The intelligent diabetes telemonitoring using decision support to treat patients on insulin therapy (DiaTRUST) trial: study protocol for a randomized controlled trial Trials Diabetes care Type 2 diabetes Telemonitoring Clinical decision support Insulin therapy |
| title | The intelligent diabetes telemonitoring using decision support to treat patients on insulin therapy (DiaTRUST) trial: study protocol for a randomized controlled trial |
| title_full | The intelligent diabetes telemonitoring using decision support to treat patients on insulin therapy (DiaTRUST) trial: study protocol for a randomized controlled trial |
| title_fullStr | The intelligent diabetes telemonitoring using decision support to treat patients on insulin therapy (DiaTRUST) trial: study protocol for a randomized controlled trial |
| title_full_unstemmed | The intelligent diabetes telemonitoring using decision support to treat patients on insulin therapy (DiaTRUST) trial: study protocol for a randomized controlled trial |
| title_short | The intelligent diabetes telemonitoring using decision support to treat patients on insulin therapy (DiaTRUST) trial: study protocol for a randomized controlled trial |
| title_sort | intelligent diabetes telemonitoring using decision support to treat patients on insulin therapy diatrust trial study protocol for a randomized controlled trial |
| topic | Diabetes care Type 2 diabetes Telemonitoring Clinical decision support Insulin therapy |
| url | https://doi.org/10.1186/s13063-024-08588-7 |
| work_keys_str_mv | AT camillahnthomsen theintelligentdiabetestelemonitoringusingdecisionsupporttotreatpatientsoninsulintherapydiatrusttrialstudyprotocolforarandomizedcontrolledtrial AT jannietdnørlev theintelligentdiabetestelemonitoringusingdecisionsupporttotreatpatientsoninsulintherapydiatrusttrialstudyprotocolforarandomizedcontrolledtrial AT stinehangaard theintelligentdiabetestelemonitoringusingdecisionsupporttotreatpatientsoninsulintherapydiatrusttrialstudyprotocolforarandomizedcontrolledtrial AT mortenhjensen theintelligentdiabetestelemonitoringusingdecisionsupporttotreatpatientsoninsulintherapydiatrusttrialstudyprotocolforarandomizedcontrolledtrial AT olehejlesen theintelligentdiabetestelemonitoringusingdecisionsupporttotreatpatientsoninsulintherapydiatrusttrialstudyprotocolforarandomizedcontrolledtrial AT sarahrcohen theintelligentdiabetestelemonitoringusingdecisionsupporttotreatpatientsoninsulintherapydiatrusttrialstudyprotocolforarandomizedcontrolledtrial AT allankofoedenevoldsen theintelligentdiabetestelemonitoringusingdecisionsupporttotreatpatientsoninsulintherapydiatrusttrialstudyprotocolforarandomizedcontrolledtrial AT sikanskristensen theintelligentdiabetestelemonitoringusingdecisionsupporttotreatpatientsoninsulintherapydiatrusttrialstudyprotocolforarandomizedcontrolledtrial AT tinnabaradottir theintelligentdiabetestelemonitoringusingdecisionsupporttotreatpatientsoninsulintherapydiatrusttrialstudyprotocolforarandomizedcontrolledtrial AT annekaas theintelligentdiabetestelemonitoringusingdecisionsupporttotreatpatientsoninsulintherapydiatrusttrialstudyprotocolforarandomizedcontrolledtrial AT petervestergaard theintelligentdiabetestelemonitoringusingdecisionsupporttotreatpatientsoninsulintherapydiatrusttrialstudyprotocolforarandomizedcontrolledtrial AT thomaskronborg theintelligentdiabetestelemonitoringusingdecisionsupporttotreatpatientsoninsulintherapydiatrusttrialstudyprotocolforarandomizedcontrolledtrial AT camillahnthomsen intelligentdiabetestelemonitoringusingdecisionsupporttotreatpatientsoninsulintherapydiatrusttrialstudyprotocolforarandomizedcontrolledtrial AT jannietdnørlev intelligentdiabetestelemonitoringusingdecisionsupporttotreatpatientsoninsulintherapydiatrusttrialstudyprotocolforarandomizedcontrolledtrial AT stinehangaard intelligentdiabetestelemonitoringusingdecisionsupporttotreatpatientsoninsulintherapydiatrusttrialstudyprotocolforarandomizedcontrolledtrial AT mortenhjensen intelligentdiabetestelemonitoringusingdecisionsupporttotreatpatientsoninsulintherapydiatrusttrialstudyprotocolforarandomizedcontrolledtrial AT olehejlesen intelligentdiabetestelemonitoringusingdecisionsupporttotreatpatientsoninsulintherapydiatrusttrialstudyprotocolforarandomizedcontrolledtrial AT sarahrcohen intelligentdiabetestelemonitoringusingdecisionsupporttotreatpatientsoninsulintherapydiatrusttrialstudyprotocolforarandomizedcontrolledtrial AT allankofoedenevoldsen intelligentdiabetestelemonitoringusingdecisionsupporttotreatpatientsoninsulintherapydiatrusttrialstudyprotocolforarandomizedcontrolledtrial AT sikanskristensen intelligentdiabetestelemonitoringusingdecisionsupporttotreatpatientsoninsulintherapydiatrusttrialstudyprotocolforarandomizedcontrolledtrial AT tinnabaradottir intelligentdiabetestelemonitoringusingdecisionsupporttotreatpatientsoninsulintherapydiatrusttrialstudyprotocolforarandomizedcontrolledtrial AT annekaas intelligentdiabetestelemonitoringusingdecisionsupporttotreatpatientsoninsulintherapydiatrusttrialstudyprotocolforarandomizedcontrolledtrial AT petervestergaard intelligentdiabetestelemonitoringusingdecisionsupporttotreatpatientsoninsulintherapydiatrusttrialstudyprotocolforarandomizedcontrolledtrial AT thomaskronborg intelligentdiabetestelemonitoringusingdecisionsupporttotreatpatientsoninsulintherapydiatrusttrialstudyprotocolforarandomizedcontrolledtrial |